Menzel Garry E is President and CEO of Tcr2 Therapeutics Inc.
Person profile
Roles
Tcr2 Therapeutics
President and CEO
Adaptimmune Therapeutics
Director
Address
San Diego, California
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Stoke Therapeutics, Inc.
7 Jun 24
4
Black Diamond Therapeutics, Inc.
6 Jun 24
4
Adaptimmune Therapeutics PLC
10 Jul 23
4
Adaptimmune Therapeutics PLC
5 Jul 23
4
Adaptimmune Therapeutics PLC
3 Jul 23
4
Stoke Therapeutics, Inc.
15 Jun 23
4
Adaptimmune Therapeutics PLC
1 Jun 23
3
Adaptimmune Therapeutics PLC
1 Jun 23
4
TCR2 THERAPEUTICS INC.
1 Jun 23
4
Black Diamond Therapeutics, Inc.
17 May 23
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
6 Jun 24 | BDTX Black Diamond Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 4.65 | 30,550 | 142.06 k | 30,550 |
5 Jun 24 | STOK Stoke Therapeutics | Director Stock Option Common Stock | Grant | Acquire A | No | No | 16.41 | 7,639 | 125.36 k | 7,639 |
3 Jul 23 | ADAP Adaptimmune Therapeutics | Option to purchase Ordinary Shares Ordinary Shares | Grant | Acquire A | No | No | 0.16 | 981,463 | 157.03 k | 981,463 |
13 Jun 23 | STOK Stoke Therapeutics | Director Stock Option Common Stock | Grant | Acquire A | No | No | 12.46 | 19,441 | 242.23 k | 19,441 |
1 Jun 23 | TCRR Tcr2 Therapeutics | Common Stock | Sale back to company | Dispose D | No | No | 0 | 138,871 | 0.00 | 0 |
1 Jun 23 | TCRR Tcr2 Therapeutics | Common Stock | Sale back to company | Dispose D | Yes | No | 0 | 132,730 | 0.00 | 0 |
1 Jun 23 | TCRR Tcr2 Therapeutics | Common Stock | Sale back to company | Dispose D | Yes | No | 0 | 132,729 | 0.00 | 0 |
1 Jun 23 | TCRR Tcr2 Therapeutics | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 39,681 | 0.00 | 0 |
1 Jun 23 | TCRR Tcr2 Therapeutics | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 23,165 | 0.00 | 0 |
1 Jun 23 | TCRR Tcr2 Therapeutics | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 15,120 | 0.00 | 0 |